Publikationen

Auswahl Publikationen ab 2020

Slot MIE, van Hell HH, Winter-van Rossum I, Gifford G, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj BY, McDonald C, van Amelsvoort T, Arango C, Falkenberg I, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Kwon JS, McGuire P, Kahn RS. 2025. Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCAN. Schizophrenia Research: Cognition, Volume 43, 100391,ISSN 2215-0013. doi: 10.1016/j.scog.2025.100391

Sachs G, Erfurth A. 2025. Combining pharmacotherapy and cognitive training in schizophrenia: Effekts on cognition and functional outcompe. International Journal of Neuropsychopharmacology, 2025, Vol 28, pi25. doi:10.1093/ijnp/pyae059.046

Erfurth A, Sachs G. 2025. Comparison of inpatient psychiatric care for SARS-COV-2 positive and negative adults in Vienna. International Journal of Neuropsychopharmacology, 2025, Vol 28, pi128. doi:10.1093/ijnp/pyae059.221

Tognin S, Catalan A, Aymerich C, Richter A, Kempton MJ, Modinos G, Hammoud R, Gorostiza I, Vassos E, van der Gaag M, de Haan L, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, The EU-GEI High Risk Study, Valmaggia L, McGuire P. 2025. Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for Psychosis. Schizophr 11, 23. doi: 10.1038/s41537-025-00562-9

Erfurth A, Sachs G. 2025. Assessing CIAS in clinical routine. European Psychiatry, 68(S1):S70-S70. doi:10.1192/j.eurpsy.2025.211

Sachs G, Erfurth A. 2025. The role of add-on strategies (cognitive enhancers, cognitive remediation). European Psychiatry, 68(S1):S70-S71. doi:10.1192/j.eurpsy.2025.212

Sachs G, Erfurth A. 2025. Cognitive impairment in psychoses and affective disorders: addressing future challenges. European Psychiatry, 68(S1):S25-S25. doi:10.1192/j.eurpsy.2025.102

Maihofer EI, Sachs G, Erfurth A. 2025. Functional outcome in psychotic and affective inpatients: role of cognitive function. European Psychiatry, 68(S1):S123-S123. doi:10.1192/j.eurpsy.2025.342

McCutcheon RA, Pillinger T, Varvari I, Halstead S, Ayinde OO, Crossley NA, Correll CU, Hahn M, Howes OD, Kane JM, Kabir T, Konradsson-Geuken A, Lennox B, Lai Ming Hui C, Rossell SL, Solmi M, Sommer IE, Taipale H, Uchida H, Venkatasubramanian G, Warren N, Agid O, Arango C, de Bartolomeis A, Bittner RA, Bressan RA, Buchanan RW, Cecere G, Chen YEH, Citrome L, Dollfus S, Dursun SM, Ebdrup BH, Elkis H, Emsley R, Fernandez-Egea E, Fleischhacker W, Freudenreich O, Gadelha A, Gangadin SS, Gaughran F, Eduardo Cecilio Hallak J, Hasan A, Homan P, Jauhar S, Kaiser S, Soo Kwon J, Lee J, Leucht S, Libiger J, Leweke MF, MacCabe JH, Marder RS, Reis Marques T, Melle I, Mucci A, Nakajima S, O'Donoghue B, Ojagbemi A, Perry BI, Roos JL, Rubio JM, Rybakowski JK, Sachs G, Siu CO, Suzuki T, Taylor DM, Takeuchi H, Thirthalli J, Thomas N, Üçok A, Varambally S, Vasiliu O, Wagner E, Siskind D. 2025. INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia. The Lancet Psychiatry, Volume 12, Issue 5, 384 – 394

Gifford G, Avila A, Kempton MJ, Fusar-Poli P, McCutcheon RA, Coutts F, Tognin S, Valmaggia L, de Haan L, van der Gaag M, Nelson B, Pantelis C, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Ruhrmann S, Sachs G, Rutten BPF, van Os J, EU-GEI High Risk Study, McGuire P. 2025. Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI Study. Schizophrenia Bulletin, Volume 51, Issue 4, 1019–1029, doi: 10.1093/schbul/sbae133

Sachs G, Erfurth A. 2025. Role of cognitive function in functional outcome in psychotic and affective patients. International Journal of Neuropsychopharmacology. Volume 28, Issue Supplement_2, ii41–ii42, doi: 10.1093/ijnp/pyaf052.082

Mortazavi M, Amon J, Jäger I, Hasanaj G, Aminifarsani Z, Fischer K, Gamer M, Hasan A, Keefe RSE, Sachs G, Falkai P, Keeser D, Raabe F, Wagner E. 2025. Assessment of the German Version of Brief Assessment of Cognition in Schizophrenia (BACS). Schizophrenia Research: Cognition, Volume 41, 100364,ISSN 2215-0013. doi: 10.1016/j.scog.2025.100364.

Howes OD, Bukala BR, Chen EYH, Correll CU, Hasan A, Honer WG, Kane JM, Leucht S, Siafis S, Agid O, Akena D, Arango C, Atwoli L, Barnes TRE, Birnbaum ML, Bitter I, Breier A, Buchanan RW, Citrome L, Cotter DR, Crossley N, Davidson M, de Bartolomeis A, DeLisi LE, Dollfus S, Dursun SM, Ebdrup BH, Elkis H, Emsley R, Falkai P, Fernández-Egea E, Fleischhacker W, Freudenreich O, Gadelha A, Gaebel W, Graff-Guerrero A, Gridley A, Hallak JEC, Homan P, Kahn RS, Kaiser S, Kapi M, Kennedy JL, Kim E, Kinon BJ, Kwon JS, Lawrie SM, Lee J, Leweke FM, Li T, Libiger J, Marder SR, Melle I, Meltzer H, Mucci A, Naber D, Nakajima S, Nielsen J, O’Brien O, Ojagbemi A, Omlor W, Pantelis C, Peuskens J, Raedler TJ, Ran M-S, Reis Marques T, Remington G, Rossell SL, Rubio JM, Sachs G, Scott J, Si T, Siskind D, Siu CO, Sommer IE, Suzuki T, Takeuchi H, Tandon R, Taylor D, Teferra S, Thomas N, Tiihonen J, Uchida H, Ucok A, Umbricht D, Venkatasubramanian G, Wagner E, Walters JTR, Wang C, Weiser M, Wright C, Yu X, McCutcheon RA. 2025. Relapse in schizophrenia: a systematic review of criteria for clinical studies and international consensus guidelines to improve them. Am J Psychiatry, 182(11):969-983.

Si S, See C, Hedges EP, Tognin S, Modinos G, de Haan L, van der Gaag M, Nelson B, Pantelis C, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Ruhrmann S, Sachs G, Rutten BP, van Os J, Barker GJ, James A, EU-GEI High Risk Study, Valmaggia L, McGuire P, Kempton MJ. 2025. Gray matter volume abnormalities and the association with the trajectory of symptoms and functioning in individuals at clinical high risk of psychosis. Schizophrenia Bulletin, doi: 10.1093/schbul/sbaf231

Slot MIE, van Hell HH, Winter-van Rossum I, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Bressan RA, Kwon JS, Mizrahi R, McGuire P, Kahn RS. 2024. Supplements to: A naturalistic cohort study of first-episode schizophrenia spectrum disorder: a description of the early phase of illness in the PSYSCAN cohort. Elsevier. https://doi.org/10.1016/j.schres.2024.02.018

Giordano GM, Pezzella P, Mucci A, Austin SF, Erfurth A, Glenthøj B, Hofer A, Hubenak J, Libiger J, Melle I, Nielsen MØ, Rybakowski JK, Wojciak P, Galderisi S, Sachs G. 2024. Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia. Front. Psychiatry 15:1333711. doi: 10.3389/fpsyt.2024.1333711

Sachs G, Erfurth A. 2024. Kognitive Beeinträchtigung in Zusammenhang mit Schizophrenie (CIAS): Diagnostik und Therapie. psychopraxis. neuropraxis 27, 74–80. doi: 10.1007/s00739-024-00986-5

Slot MIE, van Hell HH, Winter-van Rossum I, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Bressan RA, Kwon JS, Mizrahi R, McGuire P, Kahn RS. 2024. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort, Schizophrenia Research, Volume 266, 237-248, ISSN 0920-9964, doi:10.1016/j.schres.2024.02.018.

Sachs G, Erfurth A. 2024. Cognitive and social cognitive function in patients with schizophrenia and affective disorder: effects of combining pharmacotherapy with cognitive remediation. European Psychiatry. 67(S1), 762-762. doi:10.1192/j.eurpsy.2024.1587

Aigner M, Sachs G. 2024. Diagnostik psychischer Störungen und psychopharmakologische Therapie im klinischen Alltag. Verdauungskrankheiten. Munich Bd. 42, Ausg. 4, (Jul/Aug 2024): 159. doi:10.5414/VDX01242

Formica MJC, Fuller-Tyszkiewicz M, Reininghaus U, Kempton M, Delespaul P, De Haan L, Nelson B, Mikocka-Walus A, Olive L, Ruhrmann S, Rutten B, Riecher-Rössler A, Sachs G, Valmaggia L, Van Der Gaag M, McGuire P, Van Os J, Hartmann JA. 2024. Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis. Psychological Medicine 54(9), 2254-2263. doi:10.1017/S0033291724000400

Menculini G, Cirimbilli F, Raspa V, Scopetta F, Cinesi G, Chieppa AG, Cuzzucoli L, Moretti P, Balducci PM, Attademo L, Bernardini F, Erfurth A, Sachs G, Tortorella A. 2024. Insights into the Effect of Light Pollution on Mental Health: Focus on Affective Disorders—A Narrative Review. Brain Sciences, 14(8):802. doi: 10.3390/brainsci14080802

Maihofer EIJ, Sachs G, Erfurth A. 2024. Cognitive Function in Patients with Psychotic and Affective Disorders: Effects of Combining Pharmacotherapy with Cognitive Remediation. Journal of Clinical Medicine, 13(16):4843. doi:10.3390/jcm13164843

Gifford G, Cullen AE, Vieira S, Searle A, McCutcheon RA, Modinos G, Stone WS, Hird E, Barnett J, van Hell HH, Catalan A, Millgate E, Taptiklis N, Cormack F, Slot ME, Dazzan P, Maat A, de Haan L, Crespo Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Bressan RA, Kwon JS, Weiser M, Mizrahi R, Sachs G, Kirschner M, Reichenberg A, Kahn R, McGuire P, PsyCog. 2024. A computerised mini battery for assessing cognition in psychosis. Schizophrenia Research: Cognition, Volume 37, 100310, ISSN 2215-0013. doi:10.1016/j.scog.2024.100310.

Slot MIE, Urquijo Castro MF, Winter-van Rossum I, Van Hell HH, Dwyer D, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj BY, Lawrie M, McDonald C, Gruber O, Van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Kirschner M. 2024. Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN. Schizophr 10, 89. doi: 10.1038/s41537-024-00505-w

See CRZ, Si S, Hedges E, Tognin S, Modinos G, van der Gaag M, de Haan L, Velthorst E, McGorry P, Nelson B, Riecher-Rössler A, Bressan E, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BP, van Os J, McGuire P, Valmaggia LR, Kempton MJ, EU-GEI High Risk Study. 2024. The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study. Psychological Medicine, 54(16):4768-4778. doi:10.1017/S0033291724003039

Aigner M, Sachs G. 2024. Diagnostik Psychischer Störungen und Psychopharmakologische Therapie. In: Moser, G., Goebel-Stengel, M., Stengel, A. (eds) Psychosomatik in der Gastroenterologie und Hepatologie. Springer, Berlin, Heidelberg. doi: 10.1007/978-3-662-68436-8_27

Endler PC, Altunbay A, Dietrich G, Sachs G. 2023. Beobachtende in analytischen Gruppen III: Übertragung in einer Großgruppe zwischen Pandemie und Kriegsbedrohung. Gruppenpsychotherapie und Gruppendynamik 59 (4), 287-307

Mondelli V, Blackman G, Kempton MJ, Pollak TA, Iyegbe C, Valmaggia LR, Amminger P, Barrantes-Vidal N, Bressan R, van der Gaag M, de Haan L, Krebs MO, Nordentoft M, Ruhrmann S, Riecher-Rössler A, Rutten BPF, Sachs G, Koutsouleris N. 2023. EU GEI High Risk Study, McGuire P. 2023. Serum immune markers and transition to psychosis in individuals at clinical high risk. Brain, Behavior, and Immunity 110, 290-296

Chester LA, Valmaggia LR, Kempton MJ, Chesney E, Oliver D, Hedges EP, Klatsa E, Stahl D, van der Gaag M, de Haan L, Nelson B, McGorry P, Amminger GP, Riecher‐Rössler A, Studerus E, Bressan R, Barrantes‐Vidal N, Krebs MO, Glenthøj B, Nordentoft M, Ruhrmann S, Sachs G, McGuire P, EU‐GEI High Risk Study Group, McGuire P, Valmaggia LR, Kempton MJ, Calem M, Tognin S, Modinos G, de Haan L, van der Gaag M, Velthorst E, Kraan TC, van Dam DS, Burger N, Nelson B, McGorry P, GP Amminger, Pantelis C, Politis A, Goodall J, Riecher‐Rössler A, Borgwardt S, Studerus E, Bressan R, Gadelha A, Brietzke E, Asevedo G, Asevedo E, Zugman A, Barrantes‐Vidal N, Domínguez‐Martínez T, Racioppi A, Kwapil TR, Monsonet M, Hinojosa L, Kazes M, Daban C, Bourgin J, Gay O, Mam‐Lam‐Fook C, Krebs MO, Nordholm D, Randers L, Krakauer K, Glenthøj L, Glenthøj B, Nordentoft M, Ruhrmann S, Gebhard D, Arnhold J, Klosterkötter J, Sachs G, Lasser I, Winklbaur B, Delespaul PA, Rutten BP, van Os J. 2023. Influence of cannabis use on incidence of psychosis in people at clinical high risk. Psychiatry and Clinical Neurosciences

Erfurth A, Sachs G. 2023. Wie wirken Antidepressiva? Weil sie einen Serotoninmangel im Gehirn ausgleichen? psychopraxis. neuropraxis 26 (2), 100-107

Janssen PL, Sachs G. 2023. Diagnostik in der psychodynamischen Gruppenpsychotherapie. Gruppenpsychotherapie und Gruppendynamik 59 (1), 29-45

Erfurth A, Sachs G. 2023. The Screen for Cognitive Impairment in Psychiatry (German version, SCIP-G): Validation, dimensionality analysis and practical application in inpatient psychiatric treatment. European Psychiatry 66 (S1), S375-S375

Hird EJ, Ohmuro N, Allen P, Moseley P, Kempton MJ, Modinos G, Sachs G, van der Gaag M, de Haan L, Gadelha A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Catalan A, McGuire P. 2023. Speech illusions in people at clinical high risk for psychosis linked to clinical outcome. Schizophrenia Bulletin 49 (2), 339-349

Mongan D, Focking M, Healy C, Susai SR, Heurich M, Wynne K, Nelson B, Sachs G, van der Gaag M, de Haan L, Gadelha A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Catalan A, McGuire P. 2023. Errors in the Results and Supplement (vol 78, pgno 77, 2021). JAMA PSYCHIATRY 80 (2), 191-191

Mucci A, Melle I, Sachs G, Ventura J. 2023. Negative symptoms and cognitive impairment in schizophrenia-spectrum disorders. Frontiers Media SA

Tognin S, Catalan A, Kempton MJ, Nelson B, McGorry P, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, Van Os J, De Haan L, Van Der Gaag M, McGuire P, Valmaggia LR. 2023. Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis. European Psychiatry 66 (1), e16

Erfurth A, Sachs G. 2022. Psychoedukation mittels Life-Chart-Methode. PHARMAKON 10 (6), 464-468

Hird EJ, Ohmuro N, Allen P, Moseley P, Kempton MJ, Modinos G, Sachs G, van der Gaag M, de Haan L, Gadelha A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Catalan A, McGuire P, Valmaggia LR, Calem M, Tognin S, Velthorst E, Kraan TC, van Dam DS, Burger N, Nelson B, McGorry P, Amminger GP, Pantelis C, Politis A, Goodall J, Riecher-Rössler A, Borgwardt S, Rapp C, Ittig S, Studerus E, Smieskova R, Brietzke E, Asevedo G, Asevedo E, Zugman A, Domínguez-Martínez T, Torrecilla P, Kwapil TR, Monsonet M, Hinojosa L, Kazes M, Daban C, Bourgin J, Gay O, Mam-Lam-Fook C, Krebs MO, Nordholm D, Randers L, Krakauer K, Glenthøj L, Glenthøj B, Nordentoft M, Gebhard D, Arnhold J, Klosterkötter J, Lasser I, Winklbaur B, Delespaul PA, Rutten BP, van Os J. 2022. Speech illusions in people at clinical high risk for psychosis linked to clinical outcome. Schizophrenia Bulletin

Ferrari J, Sachs G, Erfurth A. 2022. psychopraxis. neuropraxis 25 (4), 196-199

Sachs G, Bannick G, Maihofer EIJ, Voracek M, Purdon SE, Erfurth A. 2022. Dimensionality analysis of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G). Schizophrenia Research: Cognition 29, 100259

Endler CP, Enzian A, Dietrich G, Schacht S, Sachs G. 2022. Observers in analytic groups: A content analysis study from the participant perspective. Group Analysis 55 (3), 391-406

EU-GEI High Risk Study Group. 2022. Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes. Frontiers in Psychiatry 13, 869023

Sachs G. 2022. Cognitive and Social Cognitive Impairment and their Impact on Real-Life Functioning and Quality of life. European Psychiatry 65 (S1), S47-S47

Erfurth A, Sachs G. 2022. Predictors of Functional Outcome in Patients with Bipolar Disorder. European Psychiatry 65 (S1), S18-S18

Sachs G, Erfurth A. 2022. Wirkungen von Cariprazin auf Negativsymptome und kognitive Störungen bei Schizophrenie. psychopraxis. neuropraxis 25 (3), 166-171

Hedges EP, Dickson H, Tognin S, Modinos G, Antoniades M, van der Gaag M, de Haan L, McGorry P, Pantelis C, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BP, van Os J, EU-GEI High Risk Study, Valmaggia LR, McGuire P, Kempton MJ. 2022. Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis. Schizophrenia Research: Cognition 28, 100222

Catalan A, Tognin S, Kempton MJ, Stahl D, Salazar de Pablo G, Nelson B, Pantelis C, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, van Os J, de Haan L, van der Gaag M, Valmaggia LR, McGuire P. 2022. Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis. Psychological medicine 52 (8), 1569-1577

Winklbaur B, Ebner N, Sachs G, Thau K, Fischer G: 2022. Substance abuse in patients with schizophrenia. Dialogues in clinical neuroscience

Furtner J, Schöpf V, Erfurth A, Sachs G. 2022. An fMRI study of cognitive remediation in drug-naïve subjects diagnosed with first episode schizophrenia. Wiener klinische Wochenschrift 134 (5), 249-254

Vita A, Gaebel W, Mucci A, Sachs G, Barlati S, Giordano GM, Nibbio G, Nordentoft M, Wykes T, Galderisi S: 2022. European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia. European Psychiatry 65 (1), e57

Alcántara AC, Tognin s, Kempton MJ, Stahl D, Salazar de Pablo g, Nelson B, Pantelis C, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, Van Os J, De Haan L, Van der Gaag M, Valmaggia LR,McGuire P: 2022. Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis. Cambridge University Press

Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati s, Zanca F, Giordano GM, Birkedal Glenthøj L, Nordentoft M, Galderisi S. 2022. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. European Psychiatry 65 (1), e58

Sachs G, Fink B, Dietrich G. 2022. Diagnostik in der Gruppenpsychoanalyse/Psychoanalytische Psychotherapie. Psychotherapeutische Diagnostik, 101-114

Tognin S, Richter A, Kempton MJ, Modinos G, Antoniades M, Azis M, Allen P, Bossong MG, Perez J, Pantelis C, Nelson B, Amminger P, Riecher-Rössler A, Barrantes-Vidal N, Krebs MO, Glenthøj B, Ruhrmann S, Sachs G, Rutten BPF, de Haan L, van der Gaag M, Valmaggia LR, McGuire P. 2022. The relationship between grey matter volume and clinical and functional outcomes in people at clinical high risk for psychosis. Schizophrenia Bulletin Open 3 (1), sgac040

Dollfus S, Mucci A, Giordano GM, Bitter I, Austin SF, Delouche C, Erfurth A, Fleischhacker W, Movina L, Glenthøj B, Gütter K, Hofer A, Hubenak J, Kaiser S, Libiger J, Melle I, Nielsen MØ, Papsuev O, Rybakowski JK, Sachs G, Üçok A, Brando F, Wojciak P, Galderisi S. 2022. European validation of the Self-evaluation of Negative Symptoms (SNS): a large multinational and multicenter study. Frontiers in psychiatry 13

Schirmbeck F, Van der Burg NC, Blankers M, Vermeulen JM, McGuire P, Valmaggia LR, Kempton MJ, Van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, Amminger GP, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, Van Os J, Nordentoft M, Glenthøj B, Fusar-Poli P, de Haan L. 2022. Impact of comorbid affective disorders on longitudinal clinical outcomes in individuals at ultra-high risk for psychosis. Schizophrenia bulletin 48 (1), 100-110

Kempton MJ, Van der Gaag M, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Sachs G, de Haan L, Vermeulen JM. 2021. Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study. Schizophrenia Research 236, 48-53

Endler PC, Dietrich G, Sachs G. 2021. Beobachter/innen in analytischen Gruppen (II): Übertragungsphänomene aus der Beobachtungsperspektive. Gruppenpsychotherapie und Gruppendynamik 57 (3), 207-223

Erfurth A, Michael N, Roestel C, Sachs G. 2021. Informationen zu bipolaren Störungen und Darstellungen in Film und Literatur. psychopraxis. neuropraxis 24 (4), 242-246

Sachs G, Lasser I, Purdon SE, Erfurth A. 2021. Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G). Schizophrenia Research: Cognition 25, 1001971

Schirmbeck F, van der Burg N, Blankers M, Vermeulen J, McGuire P, Valmaggia L, Kempton M, Van der Gaag M, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Nelson B, Amminger GP, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, B, Van Os J, Nordentoft M, Glenthøj B, Fusar-Poli P, de Haan L. 2021. Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis. Schizophrenia bulletin, sbab0881

Furtner J, Schöpf V, Erfurth A, Sachs G. 2021. An fMRI study of cognitive remediation in drug-naïve subjects diagnosed with first episode schizophrenia. Wiener klinische Wochenschrift, 1-6 2021

Ong HL, Isvoranu AM, Schirmbeck F, McGuire P, Valmaggia L, Kempton MJ, Van Der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, Amminger GP, McGorry P, Pantelis C, Krebs MO, Nordentoft M, Glenthøj B, Ruhrmann S, Sachs G, Rutten BPF, Van Os J, De Haan L, Borsboom D. 2021. Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective. Schizophrenia Bulletin 47 (4), 1018-1028

Erfurth A, Michael N, Roestel C, Sachs G. 2021. Verlauf und Therapie bipolarer Störungen. psychopraxis. neuropraxis 24 (3), 156-1651 2021

Endler CP, Enzian A, Dietrich G, Schacht S, Sachs G. 2021. Observers in analytic groups: A content analysis study from the participant perspective. Group Analysis, 05333164211007632

Sachs G, Erfurth A. 2021. Prediction of functional outcome in bipolar disorder: Effects of cognitive remediation and cognitive psychoeducational group therapy. European Psychiatry 64 (S1), S622-S623

Sachs G, Erfurth A. 2021. Predicting functional outcome in bipolar patients: Effects of cognitive psychoeducational group therapy after 12 months. European Psychiatry 64 (S1), S81-S81 2021

Erfurth A, Sachs G. 2021. Climate change and mental health: An overview. European Psychiatry 64 (S1), S11-S11 2021

Erfurth A, Michael N, Roestel C, Sachs G. 2021. Psychoedukation für bipolare Störungen–die prospektive Life-Chart-Methode. psychopraxis. neuropraxis 24 (2), 84-971

M Dickens AM, Sen P, Kempton MJ, Neus Barrantes-Vidal N, Iyegbe C, Nordentoft M, Pollak T, Riecher-Rössler A, Ruhrmann S, Sachs G, Bressan R, Krebs MO, Amminger GP, de Haan L, van der Gaag M, Valmaggia L, Hyötyläinen T, McGuire P, Valmaggia LR, Calem M, Tognin S, Modinos G, Velthorst E, Kraan TC, van Dam DS, Burger N, Nelson B, McGorry P, Pantelis C, Politis A, Goodall J, Borgwardt S, Rapp C, Ittig S, Studerus E, Smieskova R, Gadelha A, Brietzke E, Asevedo G, Asevedo E, Zugman A, Domínguez-Martínez T, Racciopi A, Kwapil TR, Monsonet M, Rosa A, Frajerman A, Chaumette B, Bourgin J, Kebir O, Jantac C, Nordholm D, Randers L, Krakauer K, Glenthøj JL, Glenthøj B, Gebhard D, Arnhold J, Klosterkötter J, Lasser I, Winklbaur B, Delespaul PA, Rutten BP, van Os J, Orešič M. 2021. Dysregulated lipid metabolism precedes onset of psychosis. Biological psychiatry 89 (3), 288-2974

Velthorst E, JMollon J, Murray RM, de Haan L, Myin Germeys I, Glahn DC, Arango C, van der Ven E, Di Forti M, Bernardo M, Guloksuz S, Delespaul P, Mezquida G, Amoretti S, Bobes J, Saiz PA, Garcia-Portilla MP, Santos JL, Jimenez-Lopez E, Sanjuan J, Eduardo J, Aguilar E, Arrojo M, Carracedo A, Lopez G, Gonzalez-Penas J, Parellada M, Atbaşoğlu C, Saka MC, Üçok A, Alptekin K, Akdede B, Binbay T, Altınyazar V, Ulaş H, Yalınçetin B, Gümüş-Akay G, Beyaz BC, Soygür H, Cankurtaran ES, Kaymak SU, Maric NP, Mihaljevic MM, Petrovic SA, Mirjanic T, Marta Del-Ben CM, Ferraro L, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Rossi Menezes P, Morgan C, Quattrone D, Menchetti M, Selten JP, Szöke A, Tarricone I, Tortelli A, McGuire P, Valmaggia L, Kempton MJ, Van Der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, van Os J, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, van Beveren NJ, Luykx JJ, Cahn W, Simons CJP, Kahn RS, Schirmbeck F, van Winkel R, Reichenberg A. 2021. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Molecular Psychiatry, 1-153

Mongan D, Föcking M, Healy C, Susai SR, Heurich M, Wynne K, Nelson B, McGorry PD, Amminger GP, Nordentoft M, Krebs MO, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Borgwardt S, Ruhrmann S, Sachs G, Pantelis C, Van Der Gaag M, De Haan L, Valmaggia L, Pollak TA, Kempton MJ, Rutten BPF, Whelan R, Cannon M, Zammit S, Cagney G, Cotter DR, McGuire P. 2021. Development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence. JAMA psychiatry 78 (1), 77-90 2021

Sachs G, Berg A, Jagsch R, Gerhard Lenz G, Erfurth A (2020). Predictors of Functional Outcome in Patients with Bipolar Disorder: Effects of Cognitive Psychoeducational Group Therapy After 12 Months. Front Psychiatry 11, 20: 530026. doi: 10.3389/fpsyt.2020.530026.

Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango Lopez C, Kircher T, Nelson B, Galderisi S, Bressan R, Kwon JS, Weiser M, Mizrahi R, Sachs G, Maatz A, Kahn R, McGuire P; PSYSCAN Consortium . Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice. Schizophr Bull. 2020 Feb; 46(2): 432–441.doi: 10.1093/schbul/sbz067.

Modinos G, Kempton MJ, Tognin S, Calem M, Porffy L, Antoniades M, Mason A, Azis M, Allen P, Nelson B, McGorry P, Pantelis C, Riecher-Rössler A, Borgwardt S, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Glenthøj B, Ruhrmann S, Sachs G, Rutten B, van Os J, de Haan L, Velthorst E, van der Gaag M, Valmaggia LR, McGuire P; EU-GEI High Risk Study Group. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis. JAMA Psychiatry. 2020 Feb; 77(2): 190–200. Published online 2019 Nov 13. doi: 10.1001/jamapsychiatry.2019.3501

Mongan D, Föcking M, Healy C, Susai SR, Heurich M, Wynne K, Nelson B, McGorry PD, Amminger GP, Nordentoft M, Krebs MO, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Borgwardt St, Ruhrmann St, Sachs G, Pantelis Ch, van der Gaag M, de Haan L, Valmaggia L, Pollak TA, Kempton MJ, Rutten BP, Whelan R, Cannon M, Zammit St, Cagney G, Cotter DR, McGuire Ph. (2020) Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence.

JAMA Psychiatry. 2020 Aug 26: e202459. doi:10.1001/jamapsychiatry.2020.2459.

Richter R, Vassos E, Kempton MJ, van der Gaag M, de Haan L, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann St, Sachs G, Rutten B, Van Os J, Valmaggia L, McGuire Ph, EU-GEI High Risk Study (2020). Clinical Outcomes in People at High Risk for Psychosis related to Interactions between Polygenic Risk Scores and Childhood Adversity. Schizophr Bull. 2020 May; 46(Suppl 1): S104. doi: 10.1093/schbul/sbaa031.241

Pollak TA, Matthew J, Kempton MJ, Iyegbe C, Vincent A, Irani SR, Coutinho E, Menassa DA, Jacobson L, de Haan L, Ruhrmann St, Sachs G, Riecher-Rössler A, Krebs MO, Amminger P, Glenthøj B, Barrantes-Vidal N, van Os J, Rutten BPF, Bressan RA, Gaag M, Yolken R, Hotopf M, Valmaggia L, Stone J, David AS, The EUGEI High-Risk Study McGuire Ph. (2020) Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.

Molecular Psychiatry 2020 doi.org/10.1038/s41380-020-00899-w

Catalan A, Stefania Tognin St, Kempton MJ, dePablo GS, Nelson B, Pantelis Ch, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, 13, Krebs MO, Nordentoft M, Ruhrmann St, 17, Sachs G, Rutten BPF, van Os J, de Haan L, 21, van der Gaag M, EU-GEI High Risk Study Valmaggia L, McGuire Ph (2020). Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.

Psychological Medicine 1–9. doi.org/10.1017/S0033291720003396

Dickens AM, Sen P, Kempton MJ, Barrantes-Vidal N, Iyegbe C, Nordentoft M, Pollak Th, Riecher-Rössler A, Ruhrmann St, Sachs G, Bressan R, Krebs MO, Amminger GM, de Haan L, van der Gaag M, Valmaggia L, Hyötyläinen T EU-GEI High Risk Study Group Oresic M, and McGuire Ph (2020) Dysregulated Lipid Metabolism Precedes Onset of Psychosis.

Biological Psychiatry 2020 doi.org/10.1016/j.biopsych.2020.07.012

Tognin St, Catalan A, Modinos G, Kempton MJ, Bilbao A, Nelson B, Pantelis Ch, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann St, Sachs G, Rutten BPF, van Os J, de Haan L, van der Gaag M EU-GEI High Risk Study McGuire Ph, Valmaggia L (2020) Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis.

Schizophrenia Bulletin 2020 Volume 46, Issue 4, 823–833 doi.org/10.1093/schbul/sbz128

Berendsen St, Kapitein P, Schirmbeck F, van Tricht MJ, McGuire Ph, Morgan C, Gayer-Anderson Ch, Kempton MJ, Valmaggia L, Quattrone D, di Forti M, van der Gaag M, Kirkbride JB, Jongsma HE, Jones PB, Parellada M, Arango C, Arrojo M, Bernardo M, Sanjuán J, Santos JL, Szöke A, Tortelli A, Llorca PM, Tarricone I, Tripoli G, Ferraro L, La Cascia C, Lasalvia A, SarahTosato S, Menezes PR, R, Del-Ben CM, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann St, Sachs G, Rutten BPF, van Os J EU-GEI High Risk Study Velthorst E, de Haan L. EU-GEI High Risk Study (2020) Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.

Schizophrenia Research 2020 doi: 10.1016/j.schres.2020.08.001

Auswahl Publikationen ab 2010

Erfurth A, Sachs G, Lesch O. 2015. Addiction: The burden of Cyclothymic Temperament. European Psychiatry

Sachs, G, Winklbaur, B, Erfurth, A. 2016. The effects of integrated treatment with atypical antipsychotics and social cognition training on functional outcome. European Psychiatry, 33, S68

Sachs, G, Lasser, I, Winklbaur, B, Maihofer, E, Erfurth, A. 2016. The role of cognition in the psychopathology of schizophrenia: Assessment and treatment options. European Psychiatry, 33, S65

Erfurth, A, Sachs, G. 2016. From Griesinger to DSM-V: Do we need the diagnosis of schizophrenia? European Psychiatry, 33, S65

G Sachs, E Maihofer, A Erfurth. 2017. Are deficits in social cognition differentiating between schizophrenia and affective disorders. European Psychiatry, 41, S44-S45

Sachs G, Felsberger H, Furtner J, Erfurth A. 2017. Neurobiological correlates of the treatment of emotion processing in schizophrenia. European Psychiatry 41, S40

A Erfurth, G Sachs. 2017. From (Psycho) pathology to diagnosis: psychiatric nosology beyond dichotomy. European Psychiatry. 41, S45

Sachs G, Maihofer E, Swoboda H, Berg A, Lasser I, Lenz G, Erfurth A. 2018. Cognitive dysfunction and remediation in affective disorders. European Psychiatry. 48: S46

Mongan D, Föcking M, Healy C, Susai SR, Cagney G, Cannon M, Zammit St, Nelson B, McGorry P, Nordentoft M, Krebs MO, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Borgwardt St, Ruhrmann St, Sachs G, Van der Gaag M, Rutten B, Pantelis Ch, De Haan L, Valmaggia L, Kempton M, McGuire Ph, Cotter D (2020) Development of Proteomic Prediction Models for Outcomes in the Clinical High Risk State and Psychotic Experiences in Adolescence: Machine Learning Analyses in two Nested Case-Control Studies.

Schizophr Bull. 2020 May; 46(Suppl 1): S238–S239. Published online 2020 May 18. doi: 10.1093/schbul/sbaa029.581

Auswahl Publikationen ab 2003

Sachs, G, Anderer, P, Doby, D, Saletu, B, Dantendorfer, K. 2003. Impaired conditional discrimination learning in social phobia. Neuropsychobiology 47: 68-72

Sachs, G, Anderer, P, Dantendorfer, K, Saletu, B. 2004. EEG mapping in patients with social phobia. Psychiat Res-Neuroim 131: 237-247

Sachs G, Anderer P, Margreiter N, Semlitsch H, Saletu B, Katschnig H. 2004. P 300 event-related potentials and cognitive function in social phobia. Psychiat Res-Neuroim 131: 249-261

Sachs G, Steger-Wuchse D, Kryspin-Exner I, Gur RC, Katschnig H. 2004. Facial recognition deficits and cognition in schizophrenia. Schizophr Res 68: 27-35

Furtner J, Prayer D, Sachs G. 2010. Functional MRI in schizophrenia. Diagnostics and therapy monitoring of cognitive deficits of schizophrenic patients by functional MRI. Radiologe. 50(2): 131 – 135

Berger, P, Sachs G, Amering, M, Holzinger, A, Bankier, B, Katschnig, H. 2004. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. J Affect Disorder : 80:1, 75-78

Aigner, M, Sachs, G, Bruckmüller, E, Winklbaur, B, Zitterl, W, Kryspin-Exner, I, Gur, R, Katschnig H. 2007. Cognitive and emotion recognition deficits in OCD. Psychiatry Res: 149, (1-3) 121 – 128

Hofer, A, Rettenbacher, MA, Edlinger, M, Huber, R, Bodner, Th, Kemmler G, Sachs G, Fleischhacker W. Outcomes in schizophrenia outpatients treated with Amisulpride or Olanzapine. Pharmacopsychiatry 40(1): 1 – 8

Auswahl publizierter Abstracts